These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

635 related items for PubMed ID: 12483716

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Multifaceted intervention to improve rheumatologists' management of glucocorticoid-induced osteoporosis: a randomized controlled trial.
    Solomon DH, Katz JN, La Tourette AM, Coblyn JS.
    Arthritis Rheum; 2004 Jun 15; 51(3):383-7. PubMed ID: 15188323
    [Abstract] [Full Text] [Related]

  • 4. Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice.
    Ledwich LJ, Clarke K.
    J Clin Rheumatol; 2009 Mar 15; 15(2):61-4. PubMed ID: 19265346
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
    Cruse LM, Valeriano J, Vasey FB, Carter JD.
    J Clin Rheumatol; 2006 Oct 15; 12(5):221-5. PubMed ID: 17023807
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Current use of glucocorticoids in patients with rheumatoid arthritis in Germany.
    Thiele K, Buttgereit F, Huscher D, Zink A, German Collaborative Arthritis Centres.
    Arthritis Rheum; 2005 Oct 15; 53(5):740-7. PubMed ID: 16208641
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Adherence with osteoporosis practice guidelines: a multilevel analysis of patient, physician, and practice setting characteristics.
    Solomon DH, Brookhart MA, Gandhi TK, Karson A, Gharib S, Orav EJ, Shaykevich S, Licari A, Cabral D, Bates DW.
    Am J Med; 2004 Dec 15; 117(12):919-24. PubMed ID: 15629730
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prevention, diagnosis, and treatment of glucocorticoid induced osteoporosis by rheumatologists in a Latin-American city.
    Caballero-Uribe CV, Acosta-Velez JG, Hernandez-Ruiz EA, Andrade Rodado FM, Peñuela-Epalza M.
    J Clin Rheumatol; 2008 Jun 15; 14(3):153-5. PubMed ID: 18525434
    [Abstract] [Full Text] [Related]

  • 14. Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohort.
    McKeown E, Bykerk VP, De Leon F, Bonner A, Thorne C, Hitchon CA, Boire G, Haraoui B, Ferland DS, Keystone EC, Pope JE, CATCH Investigators.
    Rheumatology (Oxford); 2012 Sep 15; 51(9):1662-9. PubMed ID: 22539481
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Variations in glucocorticoid induced osteoporosis prevention in a managed care cohort.
    Mudano A, Allison J, Hill J, Rothermel T, Saag K.
    J Rheumatol; 2001 Jun 15; 28(6):1298-305. PubMed ID: 11409123
    [Abstract] [Full Text] [Related]

  • 18. Osteoporosis pharmacotherapy and counseling services in US ambulatory care clinics: opportunities for multidisciplinary interventions.
    Teschemaker A, Lee E, Xue Z, Wutoh AK.
    Am J Geriatr Pharmacother; 2008 Dec 15; 6(5):240-8. PubMed ID: 19161926
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.